Safety and Efficacy of PCSK9 Inhibitor Treatment in Heart Transplant Patients

被引：10
|
作者：
Di Nora, Concetta [1 ]
Sponga, Sandro [1 ]
Livi, Ugolino [1 ]
机构：
[1] Azienda Sanit Univ Integrata Udine, Dept Cardiothorac Sci, Udine, Italy
来源：
TRANSPLANTATION | 2019年 / 103卷 / 03期
关键词：
RISK;
D O I：
10.1097/TP.0000000000002520
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：E58 / E58
页数：1
相关论文
共 50 条
  • [31] Interplay between microRNAs, Serum Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9), and Lipid Parameters in Patients with Very High Lipoprotein(a) Treated with PCSK9 Inhibitors
    Levstek, Tina
    Karun, Tina
    Likozar, Andreja Rehberger
    Sebestjen, Miran
    Podkrajsek, Katarina Trebusak
    GENES, 2023, 14 (03)
  • [32] Efficacy of a novel PCSK9 inhibitory peptide alone and with evinacumab in a mouse model of atherosclerosis
    Inia, Jose A.
    van Nieuwkoop-van Straalen, Anita
    Jukema, J. Wouter
    Rolin, Bidda
    Staarup, Ellen Marie
    Mogensen, Christina K.
    Princen, Hans M. G.
    van den Hoek, Anita M.
    JOURNAL OF LIPID RESEARCH, 2025, 66 (03)
  • [33] The diagnostic value of echocardiography combined with serum Hcy and PCSK9 in coronary heart disease
    Wang, Liying
    Zhou, Lingling
    Wang, Lihong
    Song, Guifang
    Li, Lin
    BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS, 2024, 40 (03) : 1884 - 1893
  • [34] Cardiomyocyte-specific PCSK9 deficiency compromises mitochondrial bioenergetics and heart function
    Laudette, Marion
    Lindbom, Malin
    Arif, Muhammad
    Cinato, Mathieu
    Ruiz, Mario
    Doran, Stephen
    Miljanovic, Azra
    Rutberg, Mikael
    Andersson, Linda
    Klevstig, Martina
    Henricsson, Marcus
    Bergh, Per-Olof
    Bollano, Entela
    Aung, Nay
    Smith, J. Gustav
    Pilon, Marc
    Hyotylainen, Tuulia
    Oresic, Matej
    Perkins, Rosie
    Mardinoglu, Adil
    Levin, Malin C.
    Boren, Jan
    CARDIOVASCULAR RESEARCH, 2023, 119 (07) : 1537 - 1552
  • [35] Prevention of cardiovascular disease in patients with familial hypercholesterolaemia: The role of PCSK9 inhibitors
    Pecin, Ivan
    Hartgers, Merel L.
    Hovingh, G. Kees
    Dent, Ricardo
    Reiner, Zeljko
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2017, 24 (13) : 1383 - 1401
  • [36] Proprotein convertase subtilisin/kexin type 9 (PCSK9) and clinical outcomes in dialysis patients
    Torino, Claudia
    Carbone, Federico
    Pizzini, Patrizia
    Mezzatesta, Sabrina
    D'Arrigo, Graziella
    Gori, Mercedes
    Liberale, Luca
    Moriero, Margherita
    Michelauz, Cristina
    Fre, Federica
    Isoppo, Simone
    Gavoci, Aurora
    La Rosa, Federica
    Scuricini, Alessandro
    Tirandi, Amedeo
    Ramoni, Davide
    Mallamaci, Francesca
    Tripepi, Giovanni
    Montecucco, Fabrizio
    Zoccali, Carmine
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2024, 54 (09)
  • [37] Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol
    Schwartz, Gregory G.
    Szarek, Michael
    Bittner, Vera A.
    Diaz, Rafael
    Goodman, Shaun G.
    Jukema, J. Wouter
    Landmesser, Ulf
    Lopez-Jaramillo, Patricio
    Manvelian, Garen
    Pordy, Robert
    Scemama, Michel
    Sinnaeve, Peter R.
    White, Harvey D.
    Steg, Ph Gabriel
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 78 (05) : 421 - 433
  • [38] Recent Updates on the Use of PCSK9 Inhibitors in Patients with Atherosclerotic Cardiovascular Disease
    Dixon, Dave L.
    Pamulapati, Lauren G.
    Bucheit, John D.
    Sisson, Evan M.
    Smith, Shawn R.
    Kim, Caroline J.
    Wohlford, George F.
    Pozen, Jonah
    CURRENT ATHEROSCLEROSIS REPORTS, 2019, 21 (05)
  • [39] Relationship between PCSK9 and endothelial function in patients with acute myocardial infarction
    Cimaglia, Paolo
    Fortini, Francesca
    Sega, Francesco Vieceli Dalla
    Cardelli, Laura Sofia
    Massafra, Rodolfo Francesco
    Morelli, Cristina
    Trichilo, Michele
    Ferrari, Roberto
    Rizzo, Paola
    Campo, Gianluca
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2022, 32 (09) : 2105 - 2111
  • [40] PCSK9 and atherosclerosis burden in the coronary arteries of patients undergoing coronary angiography
    Panahi, Yunes
    Ghahrodi, Mohsen Sadeghi
    Jamshir, Mohsen
    Safarpour, Mohammad Amin
    Bianconi, Vanessa
    Pirro, Matteo
    Farahani, Maryam Moshkani
    Sahebkar, Amirhossein
    CLINICAL BIOCHEMISTRY, 2019, 74 : 12 - 18
12345